Selected Grants
Boston Children's/UCLA/Duke Next Generation Regeneration for Osteoarthritis (BUD NextGenRegen for OA)
ResearchInvestigator · Awarded by Advanced Research Projects Agency for Health · 2024 - 2029Inhibiting Rev1-mediated DNA translesion synthesis for cancer therapy
ResearchCo Investigator · Awarded by National Cancer Institute · 2024 - 2028Developing equilibrative nucleoside transporter inhibitors as non-opioid pain therapeutics
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2026Developing non-opiate GPCR signaling biased agents for pain management
ResearchCo Investigator · Awarded by Department of Defense · 2022 - 2026Triacetin Treatment for Propionic Acidemia by Rebalancing the Acetyl-CoA/Propionyl-CoA Metabolism
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2026Computational Design of Antibody-Drug-Excipient Nanoparticles
ResearchCollaborator · Awarded by National Institutes of Health · 2023 - 2026Manganese-based MRI contrast agent for quantitative myocardial perfusion imaging
ResearchCo Investigator · Awarded by LadeRx · 2024 - 2025Redox-active drug, BMX-001, as a neuroprotectant: A preventive strategy for chemotherapy induced neurotoxicity
ResearchCo-Principal Investigator · Awarded by Health and Environmental Sciences Institute · 2022 - 2024Anti-Atherogenic Mechanisms of Drebrin
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2024Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
ResearchInvestigator · Awarded by National Institutes of Health · 2015 - 2023Reformulation of Pharmaceutical to Treat ALS
ResearchCo Investigator · Awarded by North Carolina Biotechnology Center · 2020 - 2022Surface Contamination and PPE Use in Inpatient Oncology: The Impact of Covid-19
ResearchCo Investigator · Awarded by Centers for Disease Control and Prevention · 2021 - 2022Pharmacologic Suppression of Reperfusion Injury Following Endovascular Thrombectomy In Stroke
ResearchSignificant Contributor · Awarded by BioMimetix JV LLC · 2019 - 2021Role of GLUD2 as a metabolic driver of gliomas with IDH1 mutations
ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2020Development of CaMKK2 inhibitor drug for acute radiation syndrome
ResearchInvestigator · Awarded by Columbia University · 2018 - 2020The Role of IDH1 Mutations in Gliomagenesis and Metabolism
ResearchCo Investigator · Awarded by National Institutes of Health · 2009 - 2020Role of Debrin in Vascular Smooth Muscle Transdifferentiation
ResearchCollaborating Investigator · Awarded by American Heart Association · 2019 - 2019AZD9668 and Neutrophil Elastase Inhibition to Prevent Graft-versus-Host Disease
ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2019Development of mechanistically distinct androgen receptor antagonists and degraders for the treatment of advanced castration resistant prostate cancer
ResearchFacility Mgr. · Awarded by Department of Defense · 2015 - 2019Measurement of oxidative stress biomarkers in human plasma and urine
ResearchPrincipal Investigator · Awarded by University of California, Berkeley · 2016 - 2018New therapeutic strategy in reversing radiation-induced erectile dysfunction with prostate cancer pa-tients
ResearchCo Investigator · Awarded by North Carolina Biotechnology Center · 2016 - 2017Treatment of Neuropathic Pain after SCI with a Catalytic Oxidoreductant
ResearchCo Investigator · Awarded by University of Alabama at Birmingham · 2013 - 2016Fe porphyrin-based Redox Modulator in Experimental Stroke Outcome
ResearchCo Investigator · Awarded by National Institutes of Health · 2013 - 2015Biomarker Studies for Novel Anti-Cancer Agents
ResearchResearch Associate · Awarded by National Institutes of Health · 2003 - 2008External Relationships
- BioMimetix JVLLC
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.